Access Vascular was founded to address the most common and costly complications of intravenous therapy: infection, thrombosis, and phlebitis. Taking a foundationally different approach to thrombus reduction, AVI manufactures intravenous catheters from a hydrophilic material that retains significant amounts of water. Engineered to mimic the body’s natural chemistry, Access Vascular catheters are designed to evade the foreign body response and complications that come with it. Our award-winning, FDA-cleared products are HydroPICC® and HydroMID®. Recently published retrospective data on the HydroMID catheters demonstrated 6x fewer complications than a standard polyurethane midline - visit www.accessvascularinc.com to learn more.